论文部分内容阅读
近年来,随着人们对药品不良反应问题的重视,有关中药的不良反应也逐渐引起关注。2006年国家食品药品监督管理局先后通报了13种中药静脉注射剂的不良反应。全国政协委员、中国中医科学院研究员周超凡近年经过对朱砂、雄黄及中药注射剂用药安全进行充分调研后,发现成方制剂中朱砂、雄黄剂量超标问题很严重,其中不乏朱砂安神丸、牛黄解毒丸等经典名药。在今年的两会上,周超凡提出关于“加强朱砂、雄黄药用价值及中药注射剂用药安全再评价”议案引起广泛关注。近日,本刊记者就此问题专访了周超凡研究员。
In recent years, along with people’s attention to the adverse drug reactions, adverse reactions to traditional Chinese medicine have gradually attracted attention. In 2006, the State Food and Drug Administration reported the adverse reactions of 13 kinds of traditional Chinese medicine intravenous injections. Zhou Chaofan, a member of the National Committee of the Chinese People’s Political Consultative Conference and a researcher at the China Academy of Chinese Medical Sciences, has conducted a thorough investigation of the safety of cinnabar, realgar and Chinese medicine injections in recent years. He found that the excessive dose of cinnabar and realgar in Chengfang’s preparations is very serious, including Zhusha Anshen Pills and Niuhuang Jiedu Pills. Classic medicine. In this year’s two sessions, Zhou Chaofan raised widespread concern about the proposal to strengthen the reassessment of the medicinal value of cinnabar and realgar and the safety of traditional Chinese medicine injections. Recently, this reporter interviewed Zhou Chaofan’s researcher on this issue.